<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="cause" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="condition" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="joint" type="multinuc"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1002" relname="preparation">Eutrophication of natural water sources is closely linked to the distinctive appearance of massive and episodic proliferations of cyanobacteria .</segment>
<segment id="3" parent="1003" relname="contrast">These prokaryotic organisms do not systematically carry the expressed genes for toxin production ,</segment>
<segment id="4" parent="1003" relname="contrast">yet about 40 of the 150 cyanobacteria genera do possess these genes .</segment>
<segment id="5" parent="1006" relname="span">For more than two decades , microcystins</segment>
<segment id="6" parent="5" relname="restatement">( MCs )</segment>
<segment id="7" parent="1007" relname="span">have been the main family of cyanopeptides</segment>
<segment id="8" parent="7" relname="elaboration">extensively studied .</segment>
<segment id="9" parent="1009" relname="span">This dominance has been triggered by tragic incidents , such as in a Brazilian hospital in 1996 ,</segment>
<segment id="10" parent="1010" relname="span">where 52 patients</segment>
<segment id="11" parent="1011" relname="span">undergoing dialysis succumbed to liver failure</segment>
<segment id="12" parent="11" relname="elaboration">caused by contaminated water with MCs .</segment>
<segment id="13" parent="1016" relname="span">Following this , the World Health Organization</segment>
<segment id="14" parent="13" relname="elaboration">( WHO )</segment>
<segment id="15" parent="1015" relname="same_unit">has suggested regulation levels for MC-LR in drinking water</segment>
<segment id="16" parent="1015" relname="restatement">( 1 µg L−1 )</segment>
<segment id="17" parent="1017" relname="span">which was extended by the US EPA to MC-LR equivalents</segment>
<segment id="18" parent="17" relname="purpose">to include more congeners and other cyanotoxins .</segment>
<segment id="19" parent="1019" relname="span">However , several families of cyanopeptides have long been identified along with MCs</segment>
<segment id="20" parent="1020" relname="span">isolated from common cyanobacteria , i.e. , Microcystis sp. Amongst them , cyanopeptolins , anabaenopeptins</segment>
<segment id="21" parent="1021" relname="span">( APs ) , aerucyclamides , aeruginosines , and microginins are to mention</segment>
<segment id="22" parent="21" relname="circumstance">when specifying the dominant families .</segment>
<segment id="23" parent="1024" relname="span">Still , the high diversity of produced congeners from each family and the little information</segment>
<segment id="24" parent="23" relname="elaboration">known about factors and mechanisms</segment>
<segment id="25" parent="1023" relname="same_unit">linked to their production greatly complicates their study .</segment>
<segment id="26" parent="27" relname="concession">Potential cyanopeptides toxicity critically depends on the variants structure ,</segment>
<segment id="27" parent="1026" relname="span">but is still misunderstood and poorly documented .</segment>
<segment id="28" parent="1018" relname="joint">MCs are hepatotoxic</segment>
<segment id="29" parent="1018" relname="joint">and readily accumulated in the liver from the specific binding to protein phosphatases 1 and 2A .</segment>
<segment id="30" parent="1018" relname="joint">The latter causes disruption of cellular homeostasis ,</segment>
<segment id="31" parent="1018" relname="joint">and , in most acute cases , leads to liver necrosis , as well as colorectal and liver cancer .</segment>
<segment id="32" parent="1018" relname="joint">Thus far , bioactive APs are considered non-toxic .</segment>
<segment id="33" parent="1034" relname="attribution">Nevertheless , a few studies suggest</segment>
<segment id="34" parent="1034" relname="span">that some APs congeners , such as AP-A , may demonstrate the potential</segment>
<segment id="35" parent="34" relname="purpose">to inhibit protease and protein phosphatases .</segment>
<segment id="36" parent="1036" relname="same_unit">Moreover , AP-B and -F induce cyanobacteria lysis ,</segment>
<segment id="37" parent="1036" relname="same_unit">ultimately affecting the bioavailability of other cell-bound cyanotoxins .</segment>
<segment id="38" parent="1018" relname="joint">Accordingly , much still needs to be done on the unambiguous identification of these cyanopeptides and the assessment of their potential toxicity .</segment>
<segment id="39" parent="1018" relname="joint">Cyanopeptide ’s structures are characterized by cyclic or linear non-ribosomal peptides ,</segment>
<segment id="40" parent="1040" relname="span">each family possessing a characteristic substructure and some variable amino acids and peptides .</segment>
<segment id="41" parent="1042" relname="span">These variations in the core structure of each cyanopeptide multiply the number of combinations</segment>
<segment id="42" parent="41" relname="elaboration">which is the cause of the large variety of potential congeners ;</segment>
<segment id="43" parent="1043" relname="span">to date , more than 500 cyanopeptides ,</segment>
<segment id="44" parent="43" relname="elaboration">including 240 MCs and 96 APs have been identified .</segment>
<segment id="45" parent="1046" relname="preparation">More specifically , MCs are cyclic heptapeptides (</segment>
<segment id="46" parent="1047" relname="preparation">Figure 1</segment>
<segment id="47" parent="1048" relname="span">) with a characteristic β-amino acid moiety</segment>
<segment id="48" parent="1049" relname="span">named Adda</segment>
<segment id="49" parent="48" relname="elaboration">( 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid ) ,</segment>
<segment id="50" parent="1050" relname="span">and two distinctive positions with the highest variation of monomers</segment>
<segment id="51" parent="50" relname="elaboration">( X and Z ) .</segment>
<segment id="52" parent="1052" relname="span">APs are cyclic peptides</segment>
<segment id="53" parent="52" relname="elaboration">bound through a characteristic ureido-linkage (</segment>
<segment id="54" parent="1054" relname="preparation">Figure 1</segment>
<segment id="55" parent="1054" relname="joint">) ;</segment>
<segment id="56" parent="1057" relname="preparation">their structure is characterized as the following :</segment>
<segment id="57" parent="1057" relname="span">AA1-CO-[Lys-AA3-AA4-MeAA5-AA6 ]</segment>
<segment id="58" parent="1058" relname="span">with AA representing a variable amino acid residues and brackets ,</segment>
<segment id="59" parent="58" relname="elaboration">including the cyclic structure .</segment>
<segment id="60" parent="1061" relname="span">Based on the various amino acid combinations</segment>
<segment id="61" parent="60" relname="elaboration">identified for these two families ,</segment>
<segment id="62" parent="1062" relname="span">an extensive list of potential amino acids per variable sites can be proposed</segment>
<segment id="63" parent="1063" relname="span">to enumerate all possible theoretical combinations of cyanopeptides</segment>
<segment id="64" parent="63" relname="elaboration">identifiable to date .</segment>
<segment id="65" parent="1067" relname="condition">Based on the proposed combinations ,</segment>
<segment id="66" parent="1067" relname="span">one could theoretically propose a significantly higher number of congeners ,</segment>
<segment id="67" parent="68" relname="concession">although most of the variants may not occur naturally in practice ,</segment>
<segment id="68" parent="1068" relname="span">due to the low frequency of some amino acids in the possible combinations .</segment>
<segment id="69" parent="1070" relname="span">High-resolution mass spectrometry</segment>
<segment id="70" parent="69" relname="restatement">( HRMS )</segment>
<segment id="71" parent="1071" relname="span">can use exact mass measurement</segment>
<segment id="72" parent="1072" relname="span">coupled to database and software packages</segment>
<segment id="73" parent="1073" relname="span">to become an increasingly more effective tool</segment>
<segment id="74" parent="1074" relname="span">regarding the accurate identification of the suspect and unknown compounds</segment>
<segment id="75" parent="1075" relname="span">without the use of certified standards ,</segment>
<segment id="76" parent="75" relname="elaboration">where target analysis is unfeasible .</segment>
<segment id="77" parent="1078" relname="span">Suspect and non-target screening are the two main strategies</segment>
<segment id="78" parent="77" relname="elaboration">used for the exhaustive search of the known and unknown compound</segment>
<segment id="79" parent="1078" relname="elaboration">where almost no reference material is available .</segment>
<segment id="80" parent="1054" relname="joint">In recent years , the use of these screening techniques in the environmental field has greatly increased , particularly for the non-target analysis of pharmaceuticals , pesticides , hormones in surface and treated water .</segment>
<segment id="81" parent="1081" relname="span">Reversewise , the presence of cyanotoxins in surface water has only been investigated by few authors</segment>
<segment id="82" parent="81" relname="means">using this type of analysis .</segment>
<segment id="83" parent="1083" relname="span">Isobaric interferences and co-eluting substances can represent major challenges in the identification process of a compound</segment>
<segment id="84" parent="83" relname="concession">even when using HRMS .</segment>
<segment id="85" parent="1085" relname="span">Moreover , a sole analysis ,</segment>
<segment id="86" parent="1086" relname="span">based on the accurate mass , is insufficient</segment>
<segment id="87" parent="1087" relname="span">to confirm a structural identification , e.g. , determining the degradation by-products or metabolites</segment>
<segment id="88" parent="87" relname="elaboration">related to a compound of interest .</segment>
<segment id="89" parent="1090" relname="span">A non-target screening method should include various confirmatory elements , such as the accurate mass</segment>
<segment id="90" parent="89" relname="elaboration">( m/z ) ,</segment>
<segment id="91" parent="1091" relname="span">mass defect , isotopic pattern , charge states , adducts and fragmentation pattern</segment>
<segment id="92" parent="91" relname="elaboration">that increase the confidence of identification .</segment>
<segment id="93" parent="1093" relname="span">Suspect screening includes the benefit and disadvantage</segment>
<segment id="94" parent="93" relname="purpose">to depend on suspect lists .</segment>
<segment id="95" parent="1095" relname="span">It is mainly based on some of the information</segment>
<segment id="96" parent="95" relname="elaboration">mentioned above for the identification ,</segment>
<segment id="97" parent="1097" relname="span">but a major drawback comes from a lack of data in online libraries for some small molecule families , i.e. , cyanotoxins ,</segment>
<segment id="98" parent="97" relname="elaboration">which allow a formal identification .</segment>
<segment id="99" parent="1098" relname="span">Nonetheless , considering the possibility</segment>
<segment id="100" parent="99" relname="purpose">to build specific in-house databases for the unambiguous identification of the known and unknown cyanopeptides is promising for the study and identification of less known congeners .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1001" relname="span"/>
<group id="1003" type="multinuc" parent="1004" relname="preparation"/>
<group id="1004" type="multinuc" parent="1002" relname="span"/>
<group id="1005" type="multinuc" parent="1004" relname="joint"/>
<group id="1006" type="span" parent="1005" relname="same_unit"/>
<group id="1007" type="span" parent="1005" relname="same_unit"/>
<group id="1009" type="span" parent="1004" relname="joint"/>
<group id="1010" type="span" parent="9" relname="elaboration"/>
<group id="1011" type="span" parent="10" relname="elaboration"/>
<group id="1012" type="multinuc" parent="1004" relname="joint"/>
<group id="1013" type="span" parent="1012" relname="contrast"/>
<group id="1014" type="span" parent="1013" relname="span"/>
<group id="1015" type="multinuc" parent="1014" relname="span"/>
<group id="1016" type="span" parent="1015" relname="same_unit"/>
<group id="1017" type="span" parent="1014" relname="elaboration"/>
<group id="1018" type="multinuc" parent="1012" relname="contrast"/>
<group id="1019" type="span" parent="1018" relname="joint"/>
<group id="1020" type="span" parent="19" relname="elaboration"/>
<group id="1021" type="span" parent="20" relname="elaboration"/>
<group id="1023" type="multinuc" parent="1018" relname="joint"/>
<group id="1024" type="span" parent="1023" relname="same_unit"/>
<group id="1026" type="span" parent="1018" relname="joint"/>
<group id="1033" type="span" parent="1018" relname="joint"/>
<group id="1034" type="span" parent="1033" relname="span"/>
<group id="1036" type="multinuc" parent="1018" relname="joint"/>
<group id="1040" type="span" parent="1018" relname="joint"/>
<group id="1041" type="multinuc" parent="40" relname="elaboration"/>
<group id="1042" type="span" parent="1041" relname="same_unit"/>
<group id="1043" type="span" parent="1041" relname="same_unit"/>
<group id="1045" type="span" parent="1018" relname="joint"/>
<group id="1046" type="span" parent="1045" relname="span"/>
<group id="1047" type="multinuc" parent="1046" relname="span"/>
<group id="1048" type="span" parent="1047" relname="same_unit"/>
<group id="1049" type="span" parent="47" relname="elaboration"/>
<group id="1050" type="span" parent="1047" relname="same_unit"/>
<group id="1051" type="span" parent="1018" relname="joint"/>
<group id="1052" type="span" parent="1053" relname="preparation"/>
<group id="1053" type="span" parent="1051" relname="span"/>
<group id="1054" type="multinuc" parent="1053" relname="span"/>
<group id="1056" type="span" parent="1054" relname="joint"/>
<group id="1057" type="span" parent="1056" relname="span"/>
<group id="1058" type="span" parent="57" relname="elaboration"/>
<group id="1060" type="multinuc" parent="1054" relname="joint"/>
<group id="1061" type="span" parent="1060" relname="same_unit"/>
<group id="1062" type="span" parent="1060" relname="same_unit"/>
<group id="1063" type="span" parent="62" relname="purpose"/>
<group id="1065" type="span" parent="1054" relname="joint"/>
<group id="1066" type="span" parent="1065" relname="span"/>
<group id="1067" type="span" parent="1066" relname="span"/>
<group id="1068" type="span" parent="66" relname="cause"/>
<group id="1069" type="multinuc" parent="1066" relname="elaboration"/>
<group id="1070" type="span" parent="1069" relname="same_unit"/>
<group id="1071" type="span" parent="1069" relname="same_unit"/>
<group id="1072" type="span" parent="71" relname="elaboration"/>
<group id="1073" type="span" parent="72" relname="purpose"/>
<group id="1074" type="span" parent="73" relname="elaboration"/>
<group id="1075" type="span" parent="74" relname="circumstance"/>
<group id="1077" type="span" parent="1054" relname="joint"/>
<group id="1078" type="span" parent="1077" relname="span"/>
<group id="1081" type="span" parent="1054" relname="joint"/>
<group id="1083" type="span" parent="1054" relname="joint"/>
<group id="1085" type="span" parent="1054" relname="joint"/>
<group id="1086" type="span" parent="85" relname="elaboration"/>
<group id="1087" type="span" parent="86" relname="purpose"/>
<group id="1089" type="multinuc" parent="1054" relname="joint"/>
<group id="1090" type="span" parent="1089" relname="same_unit"/>
<group id="1091" type="span" parent="1089" relname="same_unit"/>
<group id="1093" type="span" parent="1054" relname="joint"/>
<group id="1094" type="span" parent="1054" relname="joint"/>
<group id="1095" type="span" parent="1096" relname="concession"/>
<group id="1096" type="multinuc" parent="1094" relname="span"/>
<group id="1097" type="span" parent="1096" relname="sequence"/>
<group id="1098" type="span" parent="1096" relname="sequence"/>
	</body>
</rst>
